Skip to main content Deutsch

Publications

Publications by Luzia Berchtold

2024

  • Ilhan-Mutlu A., Puhr H.C., Berchtold L., Zingerle L., Felfernig M., Weissenbacher L., Jomrich G., Asari R., Schoppmann S.F., Prager G.W., Bergen E.S., Berghoff A.S., Preusser M.
    Association of Family History with Patient Characteristics and Prognosis in a Large European Gastroesophageal Cancer Cohort.
    Wiener Klinische Wochenschrift, (2024) [bib]
    
    @ARTICLE{ilhanmutlu2024afhw,
      author = {Ilhan-Mutlu, A.~ and Puhr, H.C.~ and Berchtold, L.~ and Zingerle, L.~ and Felfernig, M.~ and Weissenbacher, L.~ and Jomrich, G.~ and Asari, R.~ and Schoppmann, S.F.~ and Prager, G.W.~ and Bergen, E.S.~ and Berghoff, A.S.~ and Preusser, M.~},
      title = {Association of Family History with Patient Characteristics and Prognosis in a Large European Gastroesophageal Cancer Cohort.},
      journal = {Wiener Klinische Wochenschrift},
      year = {2024},
      doi = {10.1007/s00508-024-02432-3}
    }
  • Tomasich E., Mühlbacher J., Wöran K., Hatziioannou T., Herac M., Kleinberger M., Berger J.M., Dibon L.K., Berchtold L., Heller G., Bergen E.S., Macher-Beer A., Prager G., Schindl M., Preusser M., Berghoff A.S.
    Immune Cell Distribution and DNA Methylation Signatures Differ between Tumor and Stroma Enriched Compartment in Pancreatic Ductal Adenocarcinoma.
    Translational Research 271, 40–51, (2024) [bib]
    
    @ARTICLE{tomasich2024icdd4051,
      author = {Tomasich, E.~ and M{\"u}hlbacher, J.~ and W{\"o}ran, K.~ and Hatziioannou, T.~ and Herac, M.~ and Kleinberger, M.~ and Berger, J.M.~ and Dibon, L.K.~ and Berchtold, L.~ and Heller, G.~ and Bergen, E.S.~ and Macher-Beer, A.~ and Prager, G.~ and Schindl, M.~ and Preusser, M.~ and Berghoff, A.S.~},
      title = {Immune Cell Distribution and DNA Methylation Signatures Differ between Tumor and Stroma Enriched Compartment in Pancreatic Ductal Adenocarcinoma.},
      journal = {Translational Research},
      year = {2024},
      volume = {271},
      pages = {40--51},
      doi = {10.1016/j.trsl.2024.05.005},
      url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193449230\&doi=10.1016%2fj.trsl.2024.05.005\&partnerID=40\&md5=e865208f1af41b9251650dc4dc57846f}
    }
  • Bartsch R., Berghoff A.S., Furtner J., Marhold M., Bergen E.S., Roider-Schur S., Mair M.J., Starzer A.M., Forstner H., Rottenmanner B., Aretin M.-B., Dieckmann K., Bago-Horvath Z., Haslacher H., Widhalm G., Ilhan-Mutlu A., Minichsdorfer C., Fuereder T., Szekeres T., Oehler L., Gruenberger B., Pfeiler G., Singer C., Weltermann A., Berchtold L., Preusser M.
    Final Outcome Analysis from the Phase II TUXEDO-1 Trial of Trastuzumab-Deruxtecan in HER2-Positive Breast Cancer Patients with Active Brain Metastases.
    Neuro-Oncology, (2024) [bib]
    
    @ARTICLE{bartsch2024foap,
      author = {Bartsch, R.~ and Berghoff, A.S.~ and Furtner, J.~ and Marhold, M.~ and Bergen, E.S.~ and Roider-Schur, S.~ and Mair, M.J.~ and Starzer, A.M.~ and Forstner, H.~ and Rottenmanner, B.~ and Aretin, M.-B.~ and Dieckmann, K.~ and Bago-Horvath, Z.~ and Haslacher, H.~ and Widhalm, G.~ and Ilhan-Mutlu, A.~ and Minichsdorfer, C.~ and Fuereder, T.~ and Szekeres, T.~ and Oehler, L.~ and Gruenberger, B.~ and Pfeiler, G.~ and Singer, C.~ and Weltermann, A.~ and Berchtold, L.~ and Preusser, M.~},
      title = {Final Outcome Analysis from the Phase II TUXEDO-1 Trial of Trastuzumab-Deruxtecan in HER2-Positive Breast Cancer Patients with Active Brain Metastases.},
      journal = {Neuro-Oncology},
      year = {2024},
      issn = {1523-5866 1522-8517},
      doi = {10.1093/neuonc/noae123},
      keywords = {breast cancer;Brain metastases;HER2-positive;trastuzumab deruxtecan}
    }

2023

  • Berger J.M., Alany A., Berchtold L., Puhr R., Friedrich A., Scheiner B., Prager G.W., Preusser M., Berghoff A.S., Bergen E.S.
    Prognosticators of Survival in Patients with Metastatic Pancreatic Cancer and Ascites.
    ESMO Open 8(6):102048, (2023) [bib]
    
    @ARTICLE{berger2023pspw102048,
      author = {Berger, J.M.~ and Alany, A.~ and Berchtold, L.~ and Puhr, R.~ and Friedrich, A.~ and Scheiner, B.~ and Prager, G.W.~ and Preusser, M.~ and Berghoff, A.S.~ and Bergen, E.S.~},
      title = {Prognosticators of Survival in Patients with Metastatic Pancreatic Cancer and Ascites.},
      journal = {ESMO Open},
      year = {2023},
      volume = {8},
      number = {6},
      pages = {102048},
      doi = {10.1016/j.esmoop.2023.102048},
      url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178970195\&doi=10.1016%2fj.esmoop.2023.102048\&partnerID=40\&md5=489421f42d413b1832076cfcf2201fb7}
    }
  • Tomasich E., Steindl A., Paiato C., Hatziioannou T., Kleinberger M., Berchtold L., Puhr R., Hainfellner J.A., Müllauer L., Widhalm G., Eckert F., Bartsch R., Heller G., Preusser M., Berghoff A.S.
    Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.
    Clinical Cancer Research 29(16), 3225–3236, (2023) [bib]
    
    @ARTICLE{tomasich2023fohb32253236,
      author = {Tomasich, E.~ and Steindl, A.~ and Paiato, C.~ and Hatziioannou, T.~ and Kleinberger, M.~ and Berchtold, L.~ and Puhr, R.~ and Hainfellner, J.A.~ and M{\"u}llauer, L.~ and Widhalm, G.~ and Eckert, F.~ and Bartsch, R.~ and Heller, G.~ and Preusser, M.~ and Berghoff, A.S.~},
      title = {Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.},
      journal = {Clinical Cancer Research},
      year = {2023},
      volume = { 29},
      number = {16},
      pages = {3225--3236},
      issn = {1557-3265 1078-0432},
      doi = {10.1158/1078-0432.CCR-23-0020}
    }
  • Mair M.J., Mitterer M., Buratti T., Berchtold L., Fong D., Preusser M.
    Timely Course of SARS-CoV-2 Infections and Vaccinations in Patients with Hemato-Oncological Diseases: Analysis of a Real-Life Cohort.
    ESMO Open 8(3):101559, (2023) [bib]
    
    @ARTICLE{mair2023tcsi101559,
      author = {Mair, M.J.~ and Mitterer, M.~ and Buratti, T.~ and Berchtold, L.~ and Fong, D.~ and Preusser, M.~},
      title = {Timely Course of SARS-CoV-2 Infections and Vaccinations in Patients with Hemato-Oncological Diseases: Analysis of a Real-Life Cohort.},
      journal = {ESMO Open},
      year = {2023},
      volume = {8},
      number = {3},
      pages = {101559},
      doi = {10.1016/j.esmoop.2023.101559},
      url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159157757\&doi=10.1016%2fj.esmoop.2023.101559\&partnerID=40\&md5=2a7f5cbf763dc4acee87077c93dc52ae}
    }
  • Berger J.M., Alany A., Puhr R., Berchtold L., Friedrich A., Scheiner B., Prager G.W., Berghoff A.S., Preusser M., Bergen E.S.
    Clinical Risk Factors for Ascites in Metastatic Pancreatic Cancer.
    ESMO Open 8(2):101200, (2023) [bib]
    
    @ARTICLE{berger2023crfa101200,
      author = {Berger, J.M.~ and Alany, A.~ and Puhr, R.~ and Berchtold, L.~ and Friedrich, A.~ and Scheiner, B.~ and Prager, G.W.~ and Berghoff, A.S.~ and Preusser, M.~ and Bergen, E.S.~},
      title = {Clinical Risk Factors for Ascites in Metastatic Pancreatic Cancer.},
      journal = {ESMO Open},
      year = {2023},
      volume = {8},
      number = {2},
      pages = {101200},
      issn = {2059-7029},
      doi = {10.1016/j.esmoop.2023.101200},
      keywords = {Female;Humans;Male;Retrospective Studies;Risk Factors;Inflammation/complications;systemic inflammation;peritoneal carcinomatosis;*Ascites/etiology/epidemiology/pathology;*Pancreatic Neoplasms/drug therapy;ascites;liver metastases;metastatic pancreatic cancer}
    }